A detailed history of Geneva Capital Management LLC transactions in Certara, Inc. stock. As of the latest transaction made, Geneva Capital Management LLC holds 5,510,209 shares of CERT stock, worth $62.2 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
5,510,209
Previous 5,472,817 0.68%
Holding current value
$62.2 Million
Previous $75.8 Million 14.87%
% of portfolio
1.1%
Previous 1.4%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$10.46 - $16.58 $391,120 - $619,959
37,392 Added 0.68%
5,510,209 $64.5 Million
Q2 2024

Aug 14, 2024

BUY
$13.36 - $18.94 $73.1 Million - $104 Million
5,472,817 New
5,472,817 $75.8 Million
Q1 2024

May 03, 2024

BUY
$15.65 - $19.45 $9.07 Million - $11.3 Million
579,349 Added 15.15%
4,404,199 $78.7 Million
Q4 2023

Feb 06, 2024

BUY
$12.12 - $18.19 $10.4 Million - $15.7 Million
860,763 Added 29.04%
3,824,850 $67.3 Million
Q3 2023

Nov 13, 2023

SELL
$13.9 - $19.58 $409,563 - $576,924
-29,465 Reduced 0.98%
2,964,087 $43.1 Million
Q2 2023

Aug 01, 2023

BUY
$16.89 - $24.64 $18.1 Million - $26.3 Million
1,069,340 Added 55.57%
2,993,552 $54.5 Million
Q1 2023

May 12, 2023

BUY
$15.9 - $24.72 $12 Million - $18.6 Million
752,843 Added 64.27%
1,924,212 $46.4 Million
Q4 2022

Feb 07, 2023

BUY
$10.7 - $17.84 $11,759 - $19,606
1,099 Added 0.09%
1,171,369 $18.8 Million
Q3 2022

Nov 02, 2022

BUY
$12.84 - $24.13 $15 Million - $28.2 Million
1,170,270 New
1,170,270 $15.5 Million

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.81B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Geneva Capital Management LLC Portfolio

Follow Geneva Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Capital Management LLC with notifications on news.